Parkinson’s Disease: Dopamine Receptor Agonists and Monoamine Oxidase B Inhibitors
From Professor Dave Explains · · 11 min

The player loads from YouTube only when you click. It uses YouTube's privacy-enhanced mode.
If the video does not play, the owner may have turned off embedding. Watch it on YouTube instead.
Description
Parkinson's disease is the second most common neurodegenerative disease behind Alzheimer's disease. What is its pathophysiology? What are the pharmacological strategies towards treatment? Let's find out!
Script by Michael Keith
Watch the whole Pharmacology playlist: http://bit.ly/ProfDavePharma
General Chemistry Tutorials: http://bit.ly/ProfDaveGenChem Organic Chemistry Tutorials: http://bit.ly/ProfDaveOrgChem Biochemistry Tutorials: http://bit.ly/ProfDaveBiochem Biology/Genetics Tutorials: http://bit.ly/ProfDaveBio Anatomy & Physiology Tutorials: http://bit.ly/ProfDaveAnatPhys Biopsychology Tutorials: http://bit.ly/ProfDaveBiopsych Microbiology/Infectious Diseases Tutorials: http://bit.ly/ProfDaveMicrobio
History of Drugs Videos: http://bit.ly/ProfDaveHistoryDrugs Immunology Tutorials: http://bit.ly/ProfDaveImmuno
EMAIL► ProfessorDaveExplains@gmail.com PATREON► http://patreon.com/ProfessorDaveExplains
Check out "Is This Wi-Fi Organic?", my book on disarming pseudoscience! Amazon: https://amzn.to/2HtNpVH Bookshop: https://bit.ly/39cKADM Barnes and Noble: https://bit.ly/3pUjmrn